UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example MedicinalProductDefinition: BupTest-5h-Transderm-SE-BS-MPD

Generated Narrative: MedicinalProductDefinition BupTest-5h-Transderm-SE-BS-MPD

identifier: http://ema.europa.eu/fhir/mpId/SE-100000843-00052809, http://ema.europa.eu/fhir/eurdId/459

domain: Human use

status: Current

combinedPharmaceuticalDoseForm: Transdermal patch

indication:

Behandling av icke maligna smärtor av måttlig intensitet när en opiod krävs för att uppnå tillräcklig smärtlindring. Buprenorphine Stada är inte lämpligt för behandling av akuta smärttillstånd. Buprenorphine Stada är avsett för vuxna.

legalStatusOfSupply: Medicinal product subject to special medical prescription

classification: buprenorphine

name

productName: Buprenorphine STADA 5 mikrogram/timme depotplåster

part

part: Buprenorphine STADA

type: Scientific name part

part

part: 5 mikrogram/timme

type: Strength part

part

part: Depotplåster

type: Pharmaceutical dose form part

Usages

-CountryLanguage
*Kingdom of SwedenSwedish